GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Central China New Life Ltd (HKSE:09983) » Definitions » EBITDA

Central China New Life (HKSE:09983) EBITDA : HK$-755 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Central China New Life EBITDA?

Central China New Life's EBITDA for the six months ended in Dec. 2023 was HK$-363 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-755 Mil.

During the past 12 months, the average EBITDA Growth Rate of Central China New Life was -175.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 7 years, the highest 3-Year average EBITDA Growth Rate of Central China New Life was 98.70% per year. The lowest was 35.00% per year. And the median was 76.00% per year.

Central China New Life's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.28. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.59.

During the past 12 months, the average EBITDA per Share Growth Rate of Central China New Life was -175.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 7 years, the highest 3-Year average EBITDA per Share Growth Rate of Central China New Life was 94.00% per year. The lowest was 32.10% per year. And the median was 78.10% per year.


Central China New Life EBITDA Historical Data

The historical data trend for Central China New Life's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central China New Life EBITDA Chart

Central China New Life Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA
Get a 7-Day Free Trial 377.01 692.40 1,086.64 927.56 -701.28

Central China New Life Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 591.35 473.80 407.97 -391.45 -363.23

Competitive Comparison of Central China New Life's EBITDA

For the Real Estate Services subindustry, Central China New Life's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central China New Life's EV-to-EBITDA Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Central China New Life's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Central China New Life's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Central China New Life's EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Central China New Life's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2023, Central China New Life's EBITDA was HK$-701 Mil.

Central China New Life's EBITDA for the quarter that ended in Dec. 2023 is calculated as

Central China New Life's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2023, Central China New Life's EBITDA was HK$-363 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-755 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Central China New Life  (HKSE:09983) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Central China New Life EBITDA Related Terms

Thank you for viewing the detailed overview of Central China New Life's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Central China New Life (HKSE:09983) Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Dirun Road Room 411, 4th floor Building 2 Jianye Office Building, Zhengdong New District, Henan Province, Zhengzhou, CHN
With over 20 years of operating history, Central China New Life, or CCNL, is the largest property management company in central China with geographical focus in Henan province. CCNL generates core revenue from providing property management services as well as value-added services to property owners and non-property owners. CCNL's coverage spans across the main cities in Henan province. The firm also seeks to leverage on the Jianye brand to provide an integrated online-to-offline service app platform called Jianye+ to deepen its penetration in Henan as a leading lifestyle service provider.
Executives
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Seatown Private Credit (cayman) Feeder Fund Ii Lp
Seatown Private Credit Feeder Fund Lp
Seatown Private Credit Master Fund
Seatown Private Credit Master Fund Ii
Seatown Singapore Feeder Fund Lp
Temasek Holdings (private) Limited
Enjoy Start Limited 2501 Other
Wu Lam Li 2501 Other
Wu Po Sum 2501 Other
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner
Morgan Stanley & Co. International Plc 2105 Underwriter
Morgan Stanley International Holdings Inc. 2201 Interest of corporation controlled by you
Morgan Stanley International Limited 2201 Interest of corporation controlled by you

Central China New Life (HKSE:09983) Headlines

No Headlines